Accessibility Menu
Otsuka logo

Otsuka(OTC) OTSKF

Current Price$66.50
Market Cap$35.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+161%
5 Year+76%
1 Year+52%
1 Month+4%
Otsuka last closing stock price
MetricPriceDate
Last closeUSD 66.502026-07-23
Otsuka stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.42%USD 65.572026-07-13
1 month+4.43%USD 63.682026-06-23
3 month-4.35%USD 69.522026-04-24
Year to date+23.36%USD 53.912025-12-31
1 year+51.92%USD 43.772025-07-22
3 year+86.52%USD 35.652023-07-21
5 year+75.74%USD 37.842021-07-19
Since inception+161.02%USD 25.482011-06-06

Otsuka Financials at a Glance

Market Cap

$35.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥2.53T

Net Income (TTM)

¥378.95B

EPS (TTM)

$4.75

P/E Ratio

14.01

Dividend

$0.88

Beta (Volatility)

0.08 (Low)

Price

$66.50

Volume

610

Open

$66.50

Previous Close

$66.50

Daily Range

$66.50 - $66.50

52-Week Range

$44.40 - $72.22

Estimated Earnings Date

Jul 31, 2026

OTSKF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Otsuka

Otsuka Holdings Co., Ltd. is a diversified healthcare company based in Tokyo, Japan, focusing on pharmaceuticals, nutraceuticals, and consumer products. The company operates through various segments, including therapeutic drugs, nutrition products, and functional chemicals, aiming to improve health and well-being globally.

Products and Services
  • Pharmaceuticals: Therapeutic drugs for central nervous system, oncology, and infectious diseases
  • Nutraceuticals: Nutrition products, health drinks, and dietary supplements
  • Consumer Products: Mineral water, food, and beverages
Growth Outlook
  • Strong demand for pharmaceuticals and nutraceuticals supports revenue growth
  • Investment in R&D to enhance product pipeline and innovation
  • Expansion into emerging markets to capture new customer segments
Financial Highlights
  • Recent quarterly revenue of 634.3 billion JPY, reflecting robust performance
  • Trailing twelve months (TTM) net income margin of 14.96%, indicating profitability
  • TTM dividend yield of 1.28%, showcasing commitment to returning value to shareholders
Otsuka Holdings Co., Ltd. has established itself as a key player in the healthcare sector, with a diverse portfolio that addresses various health needs. The company's focus on innovation and expansion positions it well for future growth, particularly in the pharmaceuticals and nutraceuticals markets. Recent financial performance highlights a strong revenue base and profitability, making it an attractive option for investors interested in the healthcare industry. The commitment to R&D and market expansion further enhances the company's growth potential, providing a solid foundation for sustained success.
AI Generated • Jul 24, 2026

Industry

Pharmaceuticals

Employees

37,758

CEO

Makoto Inoue

Headquarters

Tokyo, TY 101-0048, JP

OTSKF Financials

Key Financial Metrics (TTM)

Gross Margin

71.52%

Operating Margin

16.00%

Net Income Margin

14.96%

Return on Equity

12.85%

Return on Capital

12.65%

Return on Assets

8.94%

Earnings Yield

7.14%

Dividend Yield

1.32%

Payout Ratio

20.07%

Stock Overview

Market Cap

$35.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

527.31M

Volume

610

Avg. Volume

449.677

Financials (TTM)

Gross Profit

¥1.81T

Operating Income

¥405.13B

EBITDA

¥576.01B

Operating Cash Flow

¥409.31B

Capital Expenditure

-¥93.35B

Free Cash Flow

¥315.96B

Cash & ST Invst.

¥541.68B

Total Debt

¥195.85B

Otsuka Performance Analysis

Otsuka annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31JPY 13,213,935,879-3.1%
20232023-12-31JPY 14,355,494,6778.6%
20242024-12-31JPY 15,379,137,8237.1%
20252025-12-31JPY 16,503,342,2187.3%
Otsuka sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.6%
Q32025-09-308.2%
Q42025-12-310.6%
Q12026-03-31-2.5%
Otsuka annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31JPY 1.88-10.8%
20232023-12-31JPY 1.59-15.1%
20242024-12-31JPY 4.18162.5%
20252025-12-31JPY 4.589.5%
Otsuka sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-305.7%
Q32025-09-3042.6%
Q42025-12-31-48.2%
Q12026-03-3150.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

¥634.31B

+8.8%

Gross Profit

¥459.12B

+7.7%

Gross Margin

72.38%

N/A

Market Cap

$35.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$928.70K

N/A

Employees

37,758

N/A

Net Income

¥98.97B

+16.4%

EBITDA

¥145.94B

+0.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

¥541.68B

+32.9%

Total Debt

¥195.85B

-22.5%

Accounts Receivable

¥540.75B

+12.4%

Inventory

¥392.13B

+27.3%

Long Term Debt

¥166.00B

+31.3%

Short Term Debt

¥29.86B

-76.4%

Return on Assets

8.94%

N/A

Return on Invested Capital

11.43%

N/A

Free Cash Flow

¥84.25B

-1.3%

Operating Cash Flow

¥109.57B

+3.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TEVJFTeva Pharmaceutical Industries Limited
$28.40+0.00%
ORINYOrion Oyj
$43.02+0.00%
ALPMYAstellas Pharma Inc.
$13.21+0.92%
ALPMFAstellas Pharma Inc.
$12.85+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About OTSKF

What is the current price of Otsuka?

Otsuka is trading at $66.50 per share.

What is the 52-week range for Otsuka?

Over the past 52 weeks, Otsuka has traded between $44.40 and $72.22.

How much debt does Otsuka have?

As of the most recent reporting period, Otsuka reported total debt of ¥1.22B.

How much cash does Otsuka have on hand?

Otsuka reported ¥3.38B in cash and cash equivalents in its most recent financial results.

What is Otsuka’s dividend yield?

Otsuka currently has a dividend yield of 1.32%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.